Clinical Trial Update: Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immunogenicity and safety of GlaxoSmithKline's HPV vaccine in young males has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Warts
• Human Papillomavirus Infection
• Papillomavirus Infections

Drugs mentioned

• HPV vaccine (GlaxoSmithKline Biologicals)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus | Phase 2 | Status: COMPLETED | Results posted: 2018-09-17